Company / Capital Expenditures
CASTLE BIOSCIENCES INC Capital Expenditures History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$36.0M
FY2025
5-year range
$3.5M / $36.0M
FY2021-FY2025
Trend
+27.2%
vs FY2024
Sector context
#90 of 150
Health Care
What the data says
At $36M, CASTLE BIOSCIENCES INC's capital expenditures ranks #90 of 150 in the Health Care sector. Capital Expenditures has increased for 4 consecutive years, from $3M in FY2021 to $36M in FY2025.
Based on SEC 10-K filings.
$36M in FY2025 with a 5-year CAGR of +50.0%.
Improved from $14M to $36M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +85.6%
- 5-Year CAGR
- +50.0%
- 10-Year CAGR
- -
Sector benchmark
#90 of 150 in Health CareTop 60% of 150This company $36.0M Sector average $271.1M
▼
-86.7% below sector average
Key checks
Key Insights
- CASTLE BIOSCIENCES INC's capital expenditures has grown for 4 consecutive years.
- 5-year CAGR of +50.0%, indicating consistent growth.
- In FY2025, capital expenditures increased 27.2% year-over-year.
- Ranks #90 out of 150 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $36.0M | +27.2% |
| FY2024 | $28.3M | +108.0% |
| FY2023 | $13.6M | +141.9% |
| FY2022 | $5.6M | +61.7% |
| FY2021 | $3.5M | -26.7% |
| FY2020 | $4.8M | +407.0% |
| FY2019 | $937.0K | +238.3% |
| FY2018 | $277.0K | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026